The role of scientific museums in physics and astronomy education courses for pre-service primary school teachers

Within the Physics Education Course for pre-service primary school teachers, in the academic year 2013-14, we have developed an educational project in collaboration with the Museum of the History of Physics of Padua University and the Museum of Astronomy of Padua Astronomical Observatory. The main goals of the project were: (a) to stimulate in pre-service teachers a reflection on how scientific museums could be used for proposing effective and motivating scientific experiences within primary school curriculum, (b) make them to experience and recognize the advantages of an historical and narrative approach in the learning of a new subject. The presentations in the Museums were focused on the relation between the construction of new instruments and the evolution of scientific knowledge. Cosmological models from the ancient times up to eighteenth century were presented using instruments, paintings and significant narratives of important astronomers and physicists of the past. The effectiveness of the experience has been evaluated through a written essay that students have been asked to do at the end of both visits

Augmentative releases of Diachasmimorpha longicaudata (Hymenoptera: Braconidae) for Ceratitis capitata (Diptera: Tephritidae) control in a fruit-growing region of Argentina

Field-open augmentative releases were conducted to assess the efficacy of Diachasmimorpha longicaudata (Ashmead) for the regulation of Ceratitis capitata (Weidemann) infesting Ficus carica (L.) in a commercial area located in a fruit-producing irrigated-valley of San Juan, central-western Argentina. Parasitoids were reared on Sensitive Lethal Temperature Vienna-8 strain of C. capitata at the BioPlanta San Juan facilities, and were weekly released throughout 9 weeks over two experimental plots of ca. 2.3 ha each with a density of 5200 wasps/plot. Host mortality and medfly emergence at the release plots were significantly 1.9-times higher and 1.5-times lower, respectively, than those recorded in the control plots. D. longicaudata females increase their effectiveness on medfly at both higher temperature (22–23 °C) and relative humidity (54–62%) values. Parasitoid females used in the study showed a good ability to spread once released in open-field. Between 16 and 75% of host mortality during the parasitoid release period was due to D. longicaudata, which appears to be promising for the control of medfly in San Juan as well as in other similar Argentinean fruit-growing semi-arid regions.Fil: Sánchez, Guillermo. Provincia de San Juan. Ministerio de Producción y Desarrollo Económico. Secretaria de Agricultura, Ganadería y Agroindustria. Programa de Control y Erradicación de Mosca de los Frutos; ArgentinaFil: Murúa, Fernando. Universidad Nacional de San Juan; Argentina. Provincia de San Juan. Ministerio de Producción y Desarrollo Económico. Secretaria de Agricultura, Ganadería y Agroindustria. Programa de Control y Erradicación de Mosca de los Frutos; ArgentinaFil: Suárez, Lorena. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Provincia de San Juan. Ministerio de Producción y Desarrollo Económico. Secretaria de Agricultura, Ganadería y Agroindustria. Programa de Control y Erradicación de Mosca de los Frutos; ArgentinaFil: Van Nieuwenhove, Guido Alejandro. Fundación Miguel Lillo; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Taret, Gustavo Abelardo Ariel. Provincia de San Juan. Ministerio de Producción y Desarrollo Económico. Secretaria de Agricultura, Ganadería y Agroindustria. Programa de Control y Erradicación de Mosca de los Frutos; ArgentinaFil: Pantano, Valeria. Provincia de San Juan. Dirección de Sanidad Vegetal, Animal y Alimentos; ArgentinaFil: Bilbao, Mariana. Provincia de San Juan. Ministerio de Producción y Desarrollo Económico. Secretaria de Agricultura, Ganadería y Agroindustria. Programa de Control y Erradicación de Mosca de los Frutos; ArgentinaFil: Schliserman, Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro de Investigaciones y Transferencia de Catamarca. Universidad Nacional de Catamarca. Centro de Investigaciones y Transferencia de Catamarca; ArgentinaFil: Ovruski Alderete, Sergio Marcelo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucuman. Planta Piloto de Procesos Industriales Microbiologicos; Argentin

Relationship between prolactin plasma levels and white matter volume in women with multiple sclerosis

BACKGROUND: The role of prolactin (PRL) on tissue injury and repair mechanisms in multiple sclerosis (MS) remains unclear. The aim of this work was to investigate the relationship between PRL plasma levels and brain damage as measured by magnetic resonance imaging (MRI). METHODS: We employed a chemiluminescence immunoassay for measuring plasma levels of PRL. We used a 1.5 T scanner to acquire images and Jim 4.0 and SIENAX software to analyse them. RESULTS: We included 106 women with relapsing remitting (RR) MS and stable disease in the last two months. There was no difference in PRL plasma levels between patients with and without gadolinium enhancement on MRI. PRL plasma levels correlated with white matter volume (WMV) (rho = 0.284, p = 0.014) but not with grey matter volume (GMV). Moreover, PRL levels predicted changes in WMV (Beta: 984, p = 0.034). CONCLUSIONS: Our data of a positive association between PRL serum levels and WMV support the role of PRL in promoting myelin repair as documented in animal models of demyelination. The lack of an increase of PRL in the presence of gadolinium enhancement, contrasts with the view considering this hormone as an immune-stimulating and detrimental factor in the inflammatory process associated with MS

Oral contraceptives combined with interferon β in multiple sclerosis

Objective: To test the effect of oral contraceptives (OCs) in combination with interferon b (IFN-b) on disease activity in patients with relapsing-remitting multiple sclerosis (RRMS). Methods: One hundred fifty women with RRMS were randomized in a 1:1:1 ratio to receive IFNb-1a subcutaneously (SC) only (group 1), IFN-b-1a SC plus ethinylstradiol 20 mg and desogestrel 150 mg (group 2), or IFN-b-1a SC plus ethinylestradiol 40 mg and desogestrel 125 mg (group 3). The primary endpoint was the cumulative number of combined unique active (CUA) lesions on brain MRI at week 96. Secondary endpoints included MRI and clinical and safety measures. Results: The estimated number of cumulative CUA lesions at week 96 was 0.98 (95% confidence interval [CI] 0.81–1.14) in group 1, 0.84 (95% CI 0.66–1.02) in group 2, and 0.72 (95% CI 0.53–0.91) in group 3, with a decrease of 14.1% (p 5 0.24) and 26.5% (p 5 0.04) when comparing group 1 with groups 2 and 3, respectively. The number of patients with no gadoliniumenhancing lesions was greater in group 3 than in group 1 (p 5 0.03). No significant differences were detected in other secondary endpoints. IFN-b or OC discontinuations were equally distributed across groups. Conclusions: Our results translate the observations derived from experimental models to patients, supporting the anti-inflammatory effects of OCs with high-dose estrogens, and suggest possible directions for future research

Effect on cognition of estroprogestins combined with Interferon beta in multiple sclerosis: analysis of secondary outcomes from a randomized controlled trial

Introduction Cognitive impairment is a disabling symptom in multiple sclerosis (MS). While its management remains challenging, beneficial effects on cognition of interferon beta (IFN-β) have been reported and a positive effect from estroprogestins has been hypothesised, suggesting that the combination of the two medications in women with MS could offer a promising treatment strategy. Objectives We investigated whether a combination of estroprogestins and IFN-β can improve cognition in women with MS. Methods Women with relapsing-remitting (RR) MS were randomly assigned (1:1:1) to receive subcutaneous IFN-β-1a (Rebif®, Merck Serono, Geneva, Switzerland) 44 mcg three times a week (tiw) (group 1), subcutaneous IFN-β-1a 44 mcg tiw plus ethinyl estradiol 20 mcg and desogestrel 150 mcg (Mercilon®, MSD Italia SRL, Rome, Italy) (group 2) or subcutaneous IFN-β-1a 44 mcg tiw plus ethinyl estradiol 40 mcg and desogestrel 125 mcg (Gracial®, Organon Italia S.p.A., Rome, Italy) (group 3) in a randomised controlled trial, for which we report the analysis of secondary outcomes. At baseline and at 24 months, all patients underwent magnetic resonance imaging (MRI) and a comprehensive cognitive assessment, including Rao’s Brief Repeatable Battery (RBRB) and questionnaires for depression, fatigue and quality of life. Failure in at least two of the RBRB tests defined ‘cognitive impairment’. Results At baseline, there was no difference in the proportion of cognitively impaired patients. At month 24, the proportion of patients with cognitive impairment was lower in group 3 (34.8%) than in group 1 (47.6%) (p = 0.03). The risk of developing cognitive impairment over 24 months was lower in group 3 (p = 0.02). Mood and fatigue scores were comparable across the groups over time at both time points. However, at month 24, group 3 showed worsening on the sexual function subscale of the 54-item MS quality-of-life questionnaire (p = 0.03). Conclusions This study suggests that the combination of high-dose estroprogestins and IFN-β may have positive effects on cognition. However, the effect of this treatment on sexual function requires caution to be exercised

Control Biológico de Moscas de la Fruta en Argentina: Experiencias de Evaluación de Parasitoides contra Ceratitis capitata y Anastrepha fraterculus (Diptera: Tephritidae) en Distintas Regiones Frutihortícolas

Anastrepha fraterculus y Ceratitis capitata son actualmente importantes plagas de la frutihorticultura argentina. En consecuencia, el control biológico está siendo considerado como un componente clave en las estrategias de manejo de estas dos especies de tefrítidos plagas en distintas regiones agrícolas. Por tal motivo, se realizaron evaluaciones de parasitoides como agentes de biocontrol en la región citrícola del noroeste (subtrópico) y en la región vitivinícola del centro-oeste argentino (desértico continental). El bracónido exótico Diachasmimorpha longicaudata, un endoparasitoide de larvas, y el diaprido nativo Coptera haywardi, un endoparasitoide de pupas, fueron evaluados en condiciones ambientales naturales usando jaulas de campo en la provincia de Tucumán (noroeste). Se partió de la premisa que el uso combinado de ambos parasitoides sería más eficiente para suprimir a A. fraterculus que el uso individual de las especies. Mientras se utilizaron individualmente, la efectividad de D. longicaudata y C. haywardi fue de 75% y 56%, respectivamente. Sin embargo, la eficacia total se incrementó en un 93% cuando se usaron secuencialmente. Asimismo, la eficacia de D. longicaudata para suprimir a C. capitata fue evaluada mediante liberaciones aumentativas del parasitoide en un área productora de higos localizada en un valle frutícola de la provincia de San Juan (centro oeste). Los parasitoides fueron criados masivamente en la BioPlanta San Juan usando larvas de C. capitata de la cepa tsl Vienna-8. Las liberaciones se realizaron durante 9 semanas a una densidad aproximada de 1.200 adultos/ha. La mortalidad de la plaga y la emergencia de C. capitata en las parcelas de liberación fue 3 veces más alta y 2 veces más baja, respectivamente, que aquellas registradas en las parcelas testigos. Según los resultados, el control biológico sería una herramienta válida y complementaria dentro de las estrategias bioracionales de control de moscas de la fruta en Argentina.Fil: Ovruski Alderete, Sergio Marcelo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Planta Piloto de Procesos Industriales Microbiológicos; ArgentinaFil: Van Nieuwenhove, Guido Alejandro. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Planta Piloto de Procesos Industriales Microbiológicos; ArgentinaFil: Bezdjian, Laura Patricia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Planta Piloto de Procesos Industriales Microbiológicos; ArgentinaFil: Sánchez, Guillermo. Universidad Nacional de San Juan. Facultad de Ciencias Exactas Físicas y Naturales. Departamento de Biología; ArgentinaFil: Murúa, Fernando. Provincia de San Juan. Ministerio de Producción y Desarrollo Económico. Secretaria de Agricultura, Ganadería y Agroindustria. Programa de Control y Erradicación de Mosca de los Frutos; ArgentinaFil: Suárez, Lorena. Provincia de San Juan. Ministerio de Producción y Desarrollo Económico. Secretaria de Agricultura, Ganadería y Agroindustria. Programa de Control y Erradicación de Mosca de los Frutos; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - San Juan; ArgentinaFil: Schliserman, Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Planta Piloto de Procesos Industriales Microbiológicos; ArgentinaFil: Bilbao, Mariana. Provincia de San Juan. Ministerio de Producción y Desarrollo Económico. Secretaria de Agricultura, Ganadería y Agroindustria. Programa de Control y Erradicación de Mosca de los Frutos; ArgentinaFil: Pantano, Valeria. Provincia de San Juan. Ministerio de Producción y Desarrollo Económico. Secretaria de Agricultura, Ganadería y Agroindustria. Programa de Control y Erradicación de Mosca de los Frutos; ArgentinaFil: Taret, Gustavo. Provincia de San Juan. Ministerio de Producción y Desarrollo Económico. Secretaria de Agricultura, Ganadería y Agroindustria. Programa de Control y Erradicación de Mosca de los Frutos; ArgentinaXXVI Congresso Brasileiro de Entomología y IX Congreso Latinoamericano de EntomologíaMaceio, AlagoasBrasilSociedade Brasilera de Entomologi

Tumor Cell Phenotype Is Sustained by Selective MAPK Oxidation in Mitochondria

Mitochondria are major cellular sources of hydrogen peroxide (H2O2), the production of which is modulated by oxygen availability and the mitochondrial energy state. An increase of steady-state cell H2O2 concentration is able to control the transition from proliferating to quiescent phenotypes and to signal the end of proliferation; in tumor cells thereby, low H2O2 due to defective mitochondrial metabolism can contribute to sustain proliferation. Mitogen-activated protein kinases (MAPKs) orchestrate signal transduction and recent data indicate that are present in mitochondria and regulated by the redox state. On these bases, we investigated the mechanistic connection of tumor mitochondrial dysfunction, H2O2 yield, and activation of MAPKs in LP07 murine tumor cells with confocal microscopy, in vivo imaging and directed mutagenesis. Two redox conditions were examined: low 1 µM H2O2 increased cell proliferation in ERK1/2-dependent manner whereas high 50 µM H2O2 arrested cell cycle by p38 and JNK1/2 activation. Regarding the experimental conditions as a three-compartment model (mitochondria, cytosol, and nuclei), the different responses depended on MAPKs preferential traffic to mitochondria, where a selective activation of either ERK1/2 or p38-JNK1/2 by co-localized upstream kinases (MAPKKs) facilitated their further passage to nuclei. As assessed by mass spectra, MAPKs activation and efficient binding to cognate MAPKKs resulted from oxidation of conserved ERK1/2 or p38-JNK1/2 cysteine domains to sulfinic and sulfonic acids at a definite H2O2 level. Like this, high H2O2 or directed mutation of redox-sensitive ERK2 Cys214 impeded binding to MEK1/2, caused ERK2 retention in mitochondria and restricted shuttle to nuclei. It is surmised that selective cysteine oxidations adjust the electrostatic forces that participate in a particular MAPK-MAPKK interaction. Considering that tumor mitochondria are dysfunctional, their inability to increase H2O2 yield should disrupt synchronized MAPK oxidations and the regulation of cell cycle leading cells to remain in a proliferating phenotype

Differential diagnosis of neurodegenerative dementias with the explainable MRI based machine learning algorithm MUQUBIA

Biomarker-based differential diagnosis of the most common forms of dementia is becoming increasingly important. Machine learning (ML) may be able to address this challenge. The aim of this study was to develop and interpret a ML algorithm capable of differentiating Alzheimer's dementia, frontotemporal dementia, dementia with Lewy bodies and cognitively normal control subjects based on sociodemographic, clinical, and magnetic resonance imaging (MRI) variables. 506 subjects from 5 databases were included. MRI images were processed with FreeSurfer, LPA, and TRACULA to obtain brain volumes and thicknesses, white matter lesions and diffusion metrics. MRI metrics were used in conjunction with clinical and demographic data to perform differential diagnosis based on a Support Vector Machine model called MUQUBIA (Multimodal Quantification of Brain whIte matter biomArkers). Age, gender, Clinical Dementia Rating (CDR) Dementia Staging Instrument, and 19 imaging features formed the best set of discriminative features. The predictive model performed with an overall Area Under the Curve of 98%, high overall precision (88%), recall (88%), and F1 scores (88%) in the test group, and good Label Ranking Average Precision score (0.95) in a subset of neuropathologically assessed patients. The results of MUQUBIA were explained by the SHapley Additive exPlanations (SHAP) method. The MUQUBIA algorithm successfully classified various dementias with good performance using cost-effective clinical and MRI information, and with independent validation, has the potential to assist physicians in their clinical diagnosis

Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care

Introduction: This study aimed to address therapeutic inertia in the management of type 2 diabetes (T2D) by investigating the potential of early treatment with oral semaglutide. Methods: A cross-sectional survey was conducted between October 2021 and April 2022 among specialists treating individuals with T2D. A scientific committee designed a data collection form covering demographics, cardiovascular risk, glucose control metrics, ongoing therapies, and physician judgments on treatment appropriateness. Participants completed anonymous patient questionnaires reflecting routine clinical encounters. The preferred therapeutic regimen for each patient was also identified. Results: The analysis was conducted on 4449 patients initiating oral semaglutide. The population had a relatively short disease duration (42%  60% of patients, and more often than sitagliptin or empagliflozin. Conclusion: The study supports the potential of early implementation of oral semaglutide as a strategy to overcome therapeutic inertia and enhance T2D management

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry

Background COVID-19 sequelae can affect about 15% of patients with cancer who survive the acute phase of SARS-CoV-2 infection and can substantially impair their survival and continuity of oncological care. We aimed to investigate whether previous immunisation affects long-term sequelae in the context of evolving variants of concern of SARS-CoV-2. Methods OnCovid is an active registry that includes patients aged 18 years or older from 37 institutions across Belgium, France, Germany, Italy, Spain, and the UK with a laboratory-confirmed diagnosis of COVID-19 and a history of solid or haematological malignancy, either active or in remission, followed up from COVID-19 diagnosis until death. We evaluated the prevalence of COVID-19 sequelae in patients who survived COVID-19 and underwent a formal clinical reassessment, categorising infection according to the date of diagnosis as the omicron (B.1.1.529) phase from Dec 15, 2021, to Jan 31, 2022; the alpha (B.1.1.7)-delta (B.1.617.2) phase from Dec 1, 2020, to Dec 14, 2021; and the pre-vaccination phase from Feb 27 to Nov 30, 2020. The prevalence of overall COVID-19 sequelae was compared according to SARS-CoV-2 immunisation status and in relation to post-COVID-19 survival and resumption of systemic anticancer therapy. This study is registered with ClinicalTrials.gov, NCT04393974. Findings At the follow-up update on June 20, 2022, 1909 eligible patients, evaluated after a median of 39 days (IQR 24-68) from COVID-19 diagnosis, were included (964 [ 50 center dot 7%] of 1902 patients with sex data were female and 938 [49 center dot 3%] were male). Overall, 317 (16 center dot 6%; 95% CI 14 center dot 8-18 center dot 5) of 1909 patients had at least one sequela from COVID-19 at the first oncological reassessment. The prevalence of COVID-19 sequelae was highest in the prevaccination phase (191 [19 center dot 1%; 95% CI 16 center dot 4-22 center dot 0] of 1000 patients). The prevalence was similar in the alpha-delta phase (110 [16 center dot 8%; 13 center dot 8- 20 center dot 3] of 653 patients, p=0 center dot 24), but significantly lower in the omicron phase (16 [6 center dot 2%; 3 center dot 5-10 center dot 2] of 256 patients, p<0 center dot 0001). In the alpha- delta phase, 84 (18 center dot 3%; 95% CI 14 center dot 6-22 center dot 7) of 458 unvaccinated patients and three (9 center dot 4%; 1 center dot 9- 27 center dot 3) of 32 unvaccinated patients in the omicron phase had sequelae. Patients who received a booster and those who received two vaccine doses had a significantly lower prevalence of overall COVID-19 sequelae than unvaccinated or partially vaccinated patients (ten [7 center dot 4%; 95% CI 3 center dot 5-13 center dot 5] of 136 boosted patients, 18 [9 center dot 8%; 5 center dot 8-15 center dot 5] of 183 patients who had two vaccine doses vs 277 [ 18 center dot 5%; 16 center dot 5-20 center dot 9] of 1489 unvaccinated patients, p=0 center dot 0001), respiratory sequelae (six [4 center dot 4%; 1 center dot 6-9 center dot 6], 11 [6 center dot 0%; 3 center dot 0-10 center dot 7] vs 148 [9 center dot 9%; 8 center dot 4- 11 center dot 6], p= 0 center dot 030), and prolonged fatigue (three [2 center dot 2%; 0 center dot 1-6 center dot 4], ten [5 center dot 4%; 2 center dot 6-10 center dot 0] vs 115 [7 center dot 7%; 6 center dot 3-9 center dot 3], p=0 center dot 037)